Top Markets
Coin of the day
Xcell Therapeutics, Inc. Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110
Rang in Aktien #30681
Xcell Therapeutics Inc. engages in the development and production of drugs for... Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Aktienkurs
$0.91968646
Marktkapitalisierung
$15.91M
Veränderung (1 Tag)
2.23%
Veränderung (1 Jahr)
-54.41%
Land
KR
Handel Xcell Therapeutics, Inc. (373110)

Kategorie

Kursverlauf für Xcell Therapeutics, Inc. (373110)
Höchster Schlusskurs: $0.93 am 2026-08-01

Niedrigster Schlusskurs: $5.30 am 2024-07-01
Kursverlauf der Aktie von Xcell Therapeutics, Inc. von 2024 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 5.84%
2025 -59.67%
2024 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$527.89 35.40%
US
$996.61 50.70%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE